BioSpace News Archive

Bioniz Therapeutics, Inc., (“Bioniz”), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and autoimmune diseases, today announced the European Commission (EC) has granted orphan designation to BNZ-1 for the treatment of cutaneous T-cell lymphoma (CTCL), a rare skin cancer.

Synchrony Medical, a medical device company developing a personalized chest physiotherapy system designed to provide efficient airway clearance, has recently initiated a clinical trial at The National Cystic Fibrosis Center of Israel, at Sheba Medical Center.

Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time.

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce a Cooperative Grant award from the National Center for Advancing Translational Sciences (NCATS) at the NIH for $3.1M to support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of patients with COVID-19. SPI-1005 is an oral capsule containing ebselen

Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced the results of a pre-clinical study demonstrating that Ampion inhibits an important pro-inflammatory pathway in the types of immune cells implicated in COVID-19 and Lupus Nephritis.

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, today announced the appointment of Matt Murphy, Esq., as General Counsel.

Nexa3D, the maker of ultrafast polymer production 3D printers, announced the immediate availability of its NXD200, a new dental lab 3D printer that delivers the highest productivity, precision and performance for the dental market.

Kindeva Drug Delivery L.P. and Cambridge Healthcare Innovations Limited have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler platform technology.

Viken Detection, pioneer of x-ray imaging and analytical devices, announced that it has appointed Dr. Hanh Lai to lead its newly formed Chemical Detection and Environmental Hazards business unit.

Recognify Life Sciences, Inc. (Recognify), an atai Life Sciences (atai) platform company focused on developing treatments for cognitive impairment with initial efforts targeting Cognitive Impairment Associated with Schizophrenia (CIAS), today announced it has initiated a Phase 2a study for its lead compound RL-007,